Precision medicine in B-cell lymphoid malignancies: is it possible?
On demand Janssen satellite symposium from the virtual ESH CLL congress 2021
- What do we mean by
precision medicine in B-cell lymphoid malignancies?
Structured roundtable panel discussion: Is biology-driven clinical management possible…
Questions and answers
After participating in this symposium, delegates should be able to:
- Discuss the role of precision medicine in the management of patients with B-cell lymphoid malignancies
- Kostas Stamatopoulos (Greece)
- Gianluca Gaidano (Italy)
- Steve Treon (USA)
- Catherine Thieblemont (France)